Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) ...Middle East

PR Newswire - News
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 2, 2022 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that the company granted equity awards to 25 new employees with a grant date of September 1, 2022, as equity inducement awards outside of the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) )

Apple Storegoogle play

Also on site :



Latest News